Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.

Bagashev A, Fitzgerald MC, Larosa DF, Rose PP, Cherry S, Johnson AC, Sullivan KE.

J Interferon Cytokine Res. 2010 Nov;30(11):843-52. doi: 10.1089/jir.2010.0017. Epub 2010 Jun 29.

2.

LRRFIP1 Inhibits Hepatitis C Virus Replication by Inducing Type I Interferon in Hepatocytes.

Liu Y, Zou Z, Zhu B, Hu Z, Zeng P, Wu L.

Hepat Mon. 2015 May 23;15(5):e28473. doi: 10.5812/hepatmon.15(5)2015.28473. eCollection 2015 May.

4.

Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins.

Dai P, Jeong SY, Yu Y, Leng T, Wu W, Xie L, Chen X.

J Immunol. 2009 Mar 15;182(6):3450-60. doi: 10.4049/jimmunol.0802260.

5.

The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.

Choe N, Kwon JS, Kim JR, Eom GH, Kim Y, Nam KI, Ahn Y, Kee HJ, Kook H.

Atherosclerosis. 2013 Aug;229(2):348-55. doi: 10.1016/j.atherosclerosis.2013.05.009. Epub 2013 May 20.

PMID:
23880186
6.

Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways.

Gubern C, Camós S, Hurtado O, Rodríguez R, Romera VG, Sobrado M, Cañadas R, Moro MA, Lizasoain I, Serena J, Mallolas J, Castellanos M.

Neuroscience. 2014 May 30;268:48-65. doi: 10.1016/j.neuroscience.2014.02.051. Epub 2014 Mar 14.

PMID:
24637094
7.

Multidisciplinary Roles of LRRFIP1/GCF2 in Human Biological Systems and Diseases.

Takimoto M.

Cells. 2019 Jan 31;8(2). pii: E108. doi: 10.3390/cells8020108. Review.

8.

LRRFIP2 negatively regulates NLRP3 inflammasome activation in macrophages by promoting Flightless-I-mediated caspase-1 inhibition.

Jin J, Yu Q, Han C, Hu X, Xu S, Wang Q, Wang J, Li N, Cao X.

Nat Commun. 2013;4:2075. doi: 10.1038/ncomms3075.

9.

Regulation of IFN-alpha/beta, MxA, 2',5'-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells.

Ronni T, Matikainen S, Sareneva T, Melén K, Pirhonen J, Keskinen P, Julkunen I.

J Immunol. 1997 Mar 1;158(5):2363-74.

PMID:
9036986
10.

Anti-thrombosis effect of LRRFIP1 shRNA lentivirus in a mouse model of deep vein thrombosis.

Yin X, Wu S, Wang Z, Wang Y, Du Q, Wang A.

Thromb Res. 2013 Jul;132(1):127-31. doi: 10.1016/j.thromres.2013.05.013. Epub 2013 Jun 14.

PMID:
23751182
11.

Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.

Douchi D, Ohtsuka H, Ariake K, Masuda K, Kawasaki S, Kawaguchi K, Fukase K, Oikawa M, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M.

Cancer Lett. 2015 Aug 28;365(1):132-40. doi: 10.1016/j.canlet.2015.05.023. Epub 2015 Jun 3.

PMID:
26047573
12.

Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.

Jewell NA, Cline T, Mertz SE, Smirnov SV, Flaño E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE.

J Virol. 2010 Nov;84(21):11515-22. doi: 10.1128/JVI.01703-09. Epub 2010 Aug 25. Erratum in: J Virol. 2011 Jan;85(1):650.

13.

Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling.

Gunawardena HP, Huang Y, Kenjale R, Wang H, Xie L, Chen X.

J Biol Chem. 2011 Apr 1;286(13):10897-910. doi: 10.1074/jbc.M110.168179. Epub 2011 Jan 10.

14.

The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein.

Varga ZT, Ramos I, Hai R, Schmolke M, García-Sastre A, Fernandez-Sesma A, Palese P.

PLoS Pathog. 2011 Jun;7(6):e1002067. doi: 10.1371/journal.ppat.1002067. Epub 2011 Jun 9.

15.

The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X.

Nat Immunol. 2010 Jun;11(6):487-94. doi: 10.1038/ni.1876. Epub 2010 May 9.

PMID:
20453844
16.

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Tawaratsumida K, Phan V, Hrincius ER, High AA, Webby R, Redecke V, Häcker H.

J Virol. 2014 Aug;88(16):9038-48. doi: 10.1128/JVI.00830-14. Epub 2014 Jun 4.

17.

Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.

Stifter SA, Bhattacharyya N, Pillay R, Flórido M, Triccas JA, Britton WJ, Feng CG.

PLoS Pathog. 2016 Jan 5;12(1):e1005378. doi: 10.1371/journal.ppat.1005378. eCollection 2016 Jan.

18.

Interferon γ-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses.

Thompson MR, Sharma S, Atianand M, Jensen SB, Carpenter S, Knipe DM, Fitzgerald KA, Kurt-Jones EA.

J Biol Chem. 2014 Aug 22;289(34):23568-81. doi: 10.1074/jbc.M114.554147. Epub 2014 Jul 7.

19.

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Wang S, Chi X, Wei H, Chen Y, Chen Z, Huang S, Chen JL.

J Virol. 2014 Aug;88(15):8375-85. doi: 10.1128/JVI.00126-14. Epub 2014 May 14.

20.

Regulation of the MIR155 host gene in physiological and pathological processes.

Elton TS, Selemon H, Elton SM, Parinandi NL.

Gene. 2013 Dec 10;532(1):1-12. doi: 10.1016/j.gene.2012.12.009. Epub 2012 Dec 14. Review.

PMID:
23246696

Supplemental Content

Support Center